Connection

IRINA AGOULNIK to Female

This is a "connection" page, showing publications IRINA AGOULNIK has written about Female.
Connection Strength

0.064
  1. Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. PLoS One. 2013; 8(4):e60455.
    View in: PubMed
    Score: 0.015
  2. INPP4B: the new kid on the PI3K block. Oncotarget. 2011 Apr; 2(4):321-8.
    View in: PubMed
    Score: 0.013
  3. A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab. 2004 Dec; 89(12):6340-7.
    View in: PubMed
    Score: 0.009
  4. Repressors of androgen and progesterone receptor action. J Biol Chem. 2003 Aug 15; 278(33):31136-48.
    View in: PubMed
    Score: 0.008
  5. Relaxin signaling in uterine fibroids. Ann N Y Acad Sci. 2009 Apr; 1160:374-8.
    View in: PubMed
    Score: 0.003
  6. Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007 Mar 15; 13(6):1695-702.
    View in: PubMed
    Score: 0.003
  7. The role of relaxin in endometrial cancer. Cancer Biol Ther. 2006 Jan; 5(1):71-7.
    View in: PubMed
    Score: 0.002
  8. A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse. Nat Genet. 2000 Dec; 26(4):490-4.
    View in: PubMed
    Score: 0.002
  9. Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer. Hybridoma. 1999 Feb; 18(1):93-7.
    View in: PubMed
    Score: 0.001
  10. Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents. Anticancer Res. 1998 Sep-Oct; 18(5A):3421-6.
    View in: PubMed
    Score: 0.001
  11. Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients. Anticancer Res. 1998 May-Jun; 18(3A):1345-9.
    View in: PubMed
    Score: 0.001
  12. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. Anticancer Res. 1998 Mar-Apr; 18(2A):713-8.
    View in: PubMed
    Score: 0.001
  13. The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter. Anticancer Res. 1998 Mar-Apr; 18(2A):719-25.
    View in: PubMed
    Score: 0.001
  14. Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy. Anticancer Res. 1997 Mar-Apr; 17(2A):811-3.
    View in: PubMed
    Score: 0.001
  15. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration. Gynecol Oncol. 1996 May; 61(2):175-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.